Form 8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 


 

FORM 8-K

 


 

 

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(D) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

 

Date of Report (Date of earliest event reported) October 8, 2004

 

 


 

 

TEMPUR-PEDIC INTERNATIONAL INC.

(Exact name of registrant as specified in its charter)

 

 


 

Delaware   001-31922   33-1022198

(State or other jurisdiction

of incorporation)

  (Commission File Number)  

(IRS Employer

Identification No.)

 

1713 Jaggie Fox Way

Lexington, Kentucky 40511

(Address of principal executive offices)(Zip Code)

 

(800) 878-8889

Registrant’s telephone number, including area code

 

N/A
(Former name or former address, if changed since last report)

 


 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



Item 2.02. Results of Operations and Financial Condition.

 

On October 8, 2004, Tempur-Pedic International Inc. issued a press release providing preliminary third quarter earnings information and stating that it would be releasing its financial results for the third quarter ended September 30, 2004 on October 21, 2004. The press release is attached hereto as Exhibit 99.1 and incorporated herein.

 

The information in this report (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

 

Item 7.01. Regulation FD Disclosure.

 

The information furnished under Item 2.02 of this Form 8-K, including Exhibit 99.1 furnished herewith, is hereby incorporated by reference under this Item 7.01 as if fully set forth herein.

 

Item 9.01. Financial Statements and Exhibits.

 

(a) Financial Statements of Businesses Acquired.

 

Not applicable.

 

(b) Pro Forma Financial Information.

 

Not applicable.

 

(c) Exhibits.

 

99.1. Press release dated October 8, 2004, titled “Tempur-Pedic International Inc. Provides Preliminary Third Quarter Earnings Information.”


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: October 8, 2004

 

Tempur-Pedic International Inc.

By:

 

/s/    Robert B. Trussell, Jr.


Name:

 

Robert B. Trussell, Jr.

Title:

 

President and Chief Executive Officer


EXHIBIT INDEX

 

Exhibit

 

Description


99.1   Press release dated October 8, 2004, titled “Tempur-Pedic International Inc. Provides Preliminary Third Quarter Earnings Information.”
Press release

Exhibit 99.1

 

TEMPUR-PEDIC INTERNATIONAL INC. PROVIDES PRELIMINARY THIRD QUARTER EARNINGS INFORMATION

 

Tempur-Pedic Schedules Third Quarter 2004 Earnings Release and Conference Call.

 

LEXINGTON, KY., Friday, October 8, 7:30 a.m./PRNewswire/ — Following a number of inquiries concerning recent statements made by another participant in the bedding industry, Tempur-Pedic International Inc. (NYSE: TPX - News) announced certain preliminary third quarter 2004 financial information. For the quarter, the Company expects net sales of approximately $181 million, pro forma diluted net income per share of between $0.21 and $0.23 and GAAP diluted net income per share of between $0.20 and $0.22. The Company notes that this is preliminary information, and that its expectations are based on currently available information at the time of this release and is subject to change in conditions, many of which are outside the Company’s control. For supplemental information about the adjustments included in the pro forma net income per share information, please refer to the Company’s July 29, 2004 earnings release for the second quarter.

 

Conference Call

 

Tempur-Pedic International will release its earnings after the market closes on October 21, 2004. In connection with this earnings release the Company also expects that it will provide updated guidance for the remainder of 2004. Following the distribution of the earnings release, management of Tempur-Pedic International Inc. will host a live conference call, featuring President and Chief Executive Officer Robert Trussell and Chief Financial Officer Dale Williams, to discuss third quarter results on Thursday, October 21 at 5 p.m. Eastern Time (2 p.m. Pacific Time). The dial-in number for the conference call is 877-278-2335 or 706-634-0167. The call is also being webcast, and can be accessed at www.tempurpedic.com.

 

For those who cannot listen to the live broadcast, a replay of the call will be available from October 21, 2004 at 8:00 p.m. Eastern Time through October 28, 2004, and can be accessed by dialing 706-645-9291, conference ID #1386982.

 

The replay will be available on the Tempur-Pedic International investor relations website at http://www.tempurpedic.com/ir.

 

Forward-Looking Statements

 

This release contains “forward-looking statements,” which include information concerning the Company’s plans, objectives, goals, strategies, future revenues and performance, capital expenditures, financing needs and other information that is not historical information. When used in this release, the words “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” and variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements, including, without


limitation, management’s expectations regarding its net sales and pro forma and GAAP net income for the third quarter of 2004, are based upon current expectations and beliefs and various assumptions. There can be no assurance that the Company will realize these expectations or that these beliefs will prove correct.

 

There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements contained in this release. Numerous factors, many of which are beyond the Company’s control, could cause actual results to differ materially from those expressed as forward-looking statements. Certain of these risk factors are discussed in the Company’s filings with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K under the headings “Special Note Regarding Forward Looking Statements” and “Business-Risk Factors” filed with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made, and the Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. The Company also undertakes no obligation regarding the pre-release in the future of any information regarding its financial performance.

 

About the Company

 

Tempur-Pedic International Inc. (NYSE: TPX - News) manufactures and distributes Swedish Sleep System® mattresses and neck pillows made from the revolutionary Tempur® pressure-relieving material, a visco-elastic material that conforms to the body to provide support and help alleviate pressure points. Products are currently sold in 60 countries under the Tempur® and Tempur-Pedic® brand names. World headquarters for Tempur-Pedic International are in Lexington, KY. For more information, visit http://www.tempurpedic.com or call 800-878-8889.

 

2